Long noncoding RNA U90926 is crucial for herpes simplex virus type 1 proliferation in murine retinal photoreceptor cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
received:
01
02
2020
accepted:
22
10
2020
entrez:
11
11
2020
pubmed:
12
11
2020
medline:
11
5
2021
Statut:
epublish
Résumé
Long non-coding RNAs (lncRNAs) play vital roles in the pathogenesis of infectious diseases, but the role of lncRNAs in herpes simplex virus 1 (HSV-1) infection remains unknown. Using RNA sequencing analysis, we explored lncRNAs that were highly expressed in murine retinal photoreceptor cell-derived 661W cells infected with HSV-1. U90926 RNA (522 nucleotides) was the most upregulated lncRNA detected post HSV-1 infection. The level of U90926 RNA was continuously increased post HSV-1 infection, reaching a 100-fold increase at 24 h. Cellular fractionation showed that U90926 RNA was located in the nucleus post HSV-1 infection. Downregulation of U90926 expression by RNA interference markedly suppressed HSV-1 DNA replication (80% reduction at 12 h post infection) and HSV-1 proliferation (93% reduction at 12 h post infection) in 661W cells. The survival rates of U90926-knockdown cells were significantly increased compared to those of control cells (81% and 21%, respectively; p < 0.0001). Thus, lncRNA U90926 is crucial for HSV-1 proliferation in retinal photoreceptor cells and consequently leads to host cell death by promoting HSV-1 proliferation.
Identifiants
pubmed: 33173149
doi: 10.1038/s41598-020-76450-2
pii: 10.1038/s41598-020-76450-2
pmc: PMC7656448
doi:
Substances chimiques
RNA, Long Noncoding
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
19406Références
Nat Protoc. 2016 Sep;11(9):1650-67
pubmed: 27560171
EMBO Rep. 2016 Jul;17(7):1013-28
pubmed: 27283940
Herpes. 2001 Nov;8(3):69-73
pubmed: 11867023
RNA Biol. 2014;11(1):66-75
pubmed: 24440876
Sci Rep. 2019 Feb 4;9(1):1260
pubmed: 30718749
Cell Oncol (Dordr). 2019 Feb;42(1):1-12
pubmed: 30361825
Mol Cell. 2014 Feb 6;53(3):393-406
pubmed: 24507715
Curr Top Med Chem. 2017;17(15):1750-1757
pubmed: 27848894
Curr Opin Ophthalmol. 2001 Jun;12(3):191-5
pubmed: 11389345
Drugs. 1999 Mar;57(3):375-80; discussion 381
pubmed: 10193689
Trends Mol Med. 2018 Mar;24(3):257-277
pubmed: 29449148
Cell Rep. 2019 Jun 11;27(11):3295-3304.e4
pubmed: 31189112
Viruses. 2018 Jun 16;10(6):
pubmed: 29914164
Nanomaterials (Basel). 2017 Apr 05;7(4):
pubmed: 28379201
Biomed Res Int. 2018 Nov 11;2018:9529072
pubmed: 30534569
PLoS One. 2012;7(4):e34949
pubmed: 22532836
Cold Spring Harb Perspect Biol. 2012 Sep 01;4(9):a013011
pubmed: 22952399
J Clin Invest. 2017 Mar 1;127(3):761-771
pubmed: 28248199
Br J Pharmacol. 2013 Oct;170(4):730-47
pubmed: 23937539
Science. 2005 Sep 2;309(5740):1559-63
pubmed: 16141072
Curr Top Microbiol Immunol. 2016;394:203-36
pubmed: 26658944
Science. 2017 Nov 24;358(6366):1051-1055
pubmed: 29074580
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Int J Obes (Lond). 2017 Feb;41(2):299-308
pubmed: 27780975
Ophthalmology. 2017 Mar;124(3):382-392
pubmed: 28094044
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Bosn J Basic Med Sci. 2018 May 20;18(2):150-161
pubmed: 29669510
Int J Oral Sci. 2016 Mar 30;8(1):1-6
pubmed: 27025259
EMBO J. 2018 Jul 2;37(13):
pubmed: 29880601
Eye (Lond). 2012 Mar;26(3):370-7; quiz 378
pubmed: 22281865
Front Immunol. 2014 Nov 13;5:573
pubmed: 25431574